drugset / Trial / NCT04499209
Pharmacokinetics Study of XG005 Capsule
RandomizedParallel-groupDouble-blindBasic science
Summary
This was a Phase 1, single-center, randomized, placebo-controlled, 2-period, ascending single-dose study assessing the PK, safety, and tolerability of single ascending doses of XG005 (Period 1) and the naproxen and pregabalin combination (Period 2), in 5 dose groups each with 10 subjects.
Timeline
- Start
- 2017-10-16
- Primary completion
- 2018-01-18
- Completion
- 2018-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Naproxen | Small molecule | — | — |
| Comparator | Pregabalin | Small molecule | — | — |
| Subject | XG005 | Unknown | — | Oral |
Indications
No indication recorded.